BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 10676914)

  • 1. Late clonal diseases of treated aplastic anemia.
    Socié G; Rosenfeld S; Frickhofen N; Gluckman E; Tichelli A
    Semin Hematol; 2000 Jan; 37(1):91-101. PubMed ID: 10676914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.
    Socié G; Henry-Amar M; Bacigalupo A; Hows J; Tichelli A; Ljungman P; McCann SR; Frickhofen N; Van't Veer-Korthof E; Gluckman E
    N Engl J Med; 1993 Oct; 329(16):1152-7. PubMed ID: 8377778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cure from severe aplastic anemia in vivo and late effects.
    Socié G; Gluckman E
    Acta Haematol; 2000; 103(1):49-54. PubMed ID: 10705159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia.
    Ishihara S; Nakakuma H; Kawaguchi T; Nagakura S; Horikawa K; Hidaka M; Asou N; Mitsuya H
    Int J Hematol; 2000 Aug; 72(2):206-9. PubMed ID: 11039670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late haematological complications in severe aplastic anaemia.
    Tichelli A; Gratwohl A; Würsch A; Nissen C; Speck B
    Br J Haematol; 1988 Jul; 69(3):413-8. PubMed ID: 3044440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anemia with aplastic anemia, paroxysmal nocturnal hemoglobinuria and myelodysplastic syndromes].
    Passweg JR
    Ther Umsch; 2010 May; 67(5):251-5. PubMed ID: 20509122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
    Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
    Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late clonal complications in severe aplastic anemia.
    Tichelli A; Gratwohl A; Nissen C; Speck B
    Leuk Lymphoma; 1994 Jan; 12(3-4):167-75. PubMed ID: 8167549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplasia following aplastic anaemia-paroxysmal nocturnal haemoglobinuria syndrome after treatment with immunosuppression and G-CSF: evidence for the emergence of a separate clone.
    Jin JY; Tooze JA; Marsh JC; Matthey F; Gordon-Smith EC
    Br J Haematol; 1996 Sep; 94(3):510-2. PubMed ID: 8790151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience.
    Li Y; Li X; Ge M; Shi J; Qian L; Zheng Y; Wang J
    Ann Hematol; 2011 May; 90(5):529-37. PubMed ID: 21207031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Late complications in patients with aplastic anemia].
    Tichelli A; Gratwohl A; Nissen C; Würsch A; Signer E; Speck B
    Schweiz Med Wochenschr; 1988 Oct; 118(42):1528-32. PubMed ID: 3059487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-RAS gene mutation in patients with aplastic anemia and aplastic anemia/ paroxysmal nocturnal hemoglobinuria during evolution to clonal disease.
    Mortazavi Y; Tooze JA; Gordon-Smith EC; Rutherford TR
    Blood; 2000 Jan; 95(2):646-50. PubMed ID: 10627475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term (5 to 20 years) Evolution of nongrafted aplastic anemias. The Cooperative Group for the Study of Aplastic and Refractory Anemias.
    Najean Y; Haguenauer O
    Blood; 1990 Dec; 76(11):2222-8. PubMed ID: 2257296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia.
    Fattizzo B; Ireland R; Dunlop A; Yallop D; Kassam S; Large J; Gandhi S; Muus P; Manogaran C; Sanchez K; Consonni D; Barcellini W; Mufti GJ; Marsh JCW; Kulasekararaj AG
    Leukemia; 2021 Nov; 35(11):3223-3231. PubMed ID: 33664463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective eculizumab therapy followed by BMT in a boy with paroxysmal nocturnal hemoglobinuria.
    Oshiro H; Goi K; Akahane K; Inukai T; Sugita K
    Pediatr Int; 2015 Apr; 57(2):e27-9. PubMed ID: 25868955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential development of myelodysplasia and paroxysmal nocturnal hemoglobinuria in a patient with preceding aplastic anemia.
    Nagakura S; Kawaguchi T; Fujimoto K; Horikawa K; Iwamoto N; Nakakuma H
    Int J Hematol; 1997 Feb; 65(2):187-9. PubMed ID: 9071825
    [No Abstract]   [Full Text] [Related]  

  • 17. Living with severe aplastic anaemia for 22 years. A patient tells his story (supplemented with information from the Hematologic Clinic Basel, Switzerland).
    Kienle E; Nissen C
    Acta Haematol; 2000; 103(1):63-4. PubMed ID: 10799006
    [No Abstract]   [Full Text] [Related]  

  • 18. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could aplastic anaemia be considered a pre-pre-leukaemic disorder?
    Socié G
    Eur J Haematol Suppl; 1996; 60():60-3. PubMed ID: 8987243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clonal hematopoiesis in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
    Makishima H
    Rinsho Ketsueki; 2022; 63(9):1042-1045. PubMed ID: 36198527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.